XEME Biopharma Holdings Inc. — Regulation A 1-A
XEME Biopharma Holdings Inc. of Irvine, CA filed a Regulation A 1-A with the SEC on 2019-05-07. Aggregate offering: $10.0M (Tier 1). Industry: Other.
Offering
- Filed: 2019-05-07
- Form: 1-A
- Accession: 0001775196-19-000003
- Tier: Tier 1
- Total aggregate offering: $10.0M
- Issuer portion: $10.0M
- Selling securityholders: $18K
- Price per security: $0.1000
- Securities offered: Equity (common or preferred stock)
- Broker-dealer CRD: 0
- Audit status: Unaudited
- Auditor: Indrajith Andrew Weeraratne
- Jurisdictions: 64 states/territories
Issuer
- CIK: 0001775196
- Organized in: FL
- Incorporated: 2019
- Address: 20 Corporate Park, Irvine, CA, 92606
- Phone: 657-269-3883
- Employees: 1 full-time, 1 part-time
Financial snapshot (as filed)
- Total assets: $11K
- Cash & equivalents: $11K
- Total liabilities: $10K
- Stockholder equity: $1K
- Net income: $-133
People (2)
| Name | Role | Location |
|---|
| Indrajith Andrew Weeraratne | Signer | MIAMI BEACH, FL |
| Andrew Weeraratne | Signer | Miami Beach, FL |
Other Reg A filings by this issuer (10)
More